がん治療法の世界市場:用途別、人気商品別...市場調査レポートについてご紹介

【英文タイトル】Cancer Therapeutics Market by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others) and Top Selling Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Market share analysis, 2018
3.4. Porters five forces analysis
3.5. Clinical trials
3.6. Market dynamics

3.6.1. Drivers

3.6.1.1. Increase in prevalence of cancer
3.6.1.2. Surge in cancer research
3.6.1.3. Rise in strategic acquisitions & collaborations

3.6.2. Restraints

3.6.2.1. High cost of drug development and threat of failure
3.6.2.2. Adverse effects associated with cancer drug therapy

3.6.3. Opportunities

3.6.3.1. High potential associated with personalized medicines
3.6.3.2. Increase in purchasing power of emerging economies

CHAPTER 4: CANCER THERAPEUTICS MARKET, APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Blood cancer

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Lung cancer

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Breast cancer

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

4.5. Colorectal cancer

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

4.6. Prostate cancer

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country

4.7. Cervical cancer

4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country

4.8. Head & neck cancer

4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country

4.9. Glioblastoma

4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country

4.10. Malignant meningioma

4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast, by region
4.10.3. Market analysis, by country

4.11. Mesothelioma

4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast, by region
4.11.3. Market analysis, by country

4.12. Melanoma

4.12.1. Key market trends, growth factors, and opportunities
4.12.2. Market size and forecast, by region
4.12.3. Market analysis, by country

4.13. Others

4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast, by region
4.13.3. Market analysis, by country

CHAPTER 5: CANCER THERAPEUTICS MARKET, BY TOP SELLING DRUGS

5.1. Overview

5.1.1. Market size and forecast

5.2. Revlimid

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region

5.3. Avastin

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region

5.4. Herceptin

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region

5.5. Rituxan

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region

5.6. Opdivo

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region

5.7. Gleevec

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region

5.8. Velcade

5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by region

5.9. Imbruvica

5.9.1. Market size and forecast, by region
5.9.2. Market analysis, by region

5.10. Ibrance

5.10.1. Market size and forecast, by region
5.10.2. Market analysis, by region

5.11. Zytiga

5.11.1. Market size and forecast, by region
5.11.2. Market analysis, by region

5.12. Alimta

5.12.1. Market size and forecast, by region
5.12.2. Market analysis, by region

5.13. Xtandi

5.13.1. Market size and forecast, by region
5.13.2. Market analysis, by region

5.14. Tarceva

5.14.1. Market size and forecast, by region
5.14.2. Market analysis, by region

5.15. Perjeta

5.15.1. Market size and forecast, by region
5.15.2. Market analysis, by region

5.16. Temodar

5.16.1. Market size and forecast, by region
5.16.2. Market analysis, by region

5.17. Other drugs

5.17.1. Market size and forecast, by region
5.17.2. Market analysis, by region

CHAPTER 6: CANCER THERAPEUTICS MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America market size and forecast, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. market size and forecast, by application

6.2.2.2. Canada

6.2.2.2.1. Canada market size and forecast, by application

6.2.3. North America market size and forecast, by application
6.2.4. North America market size and forecast, by top selling drugs

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Europe cancer therapeutics market, by country

6.3.2.1. Germany

6.3.2.1.1. Germany market size and forecast, by application

6.3.2.2. France

6.3.2.2.1. France market size and forecast, by application

6.3.2.3. UK

6.3.2.3.1. UK market size and forecast, by application

6.3.2.4. Italy

6.3.2.4.1. Italy market size and forecast, by application

6.3.2.5. Spain

6.3.2.5.1. Spain market size and forecast, by application

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe market size and forecast, by application

6.3.3. Europe market size and forecast, by application
6.3.4. Europe market size and forecast, by top selling drugs

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Asia-Pacific market size and forecast, by country

6.4.2.1. Japan

6.4.2.1.1. Japan market size and forecast, by application

6.4.2.2. China

6.4.2.2.1. China market size and forecast, by application

6.4.2.3. India

6.4.2.3.1. India market size and forecast, by application

6.4.2.4. Taiwan

6.4.2.4.1. Taiwan market size and forecast, by application

6.4.2.5. South Korea

6.4.2.5.1. South Korea market size and forecast, by application

6.4.2.6. Australia

6.4.2.6.1. Australia market size and forecast, by application

6.4.2.7. Rest of Asia-Pacific

6.4.2.7.1. Rest of Asia-Pacific market size and forecast, by application

6.4.3. Asia-Pacific market size and forecast, by application
6.4.4. Asia-Pacific market size and forecast, by top selling drugs

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. LAMEA market size and forecast, by country

6.5.2.1. Latin America

6.5.2.1.1. Latin America market size and forecast, by application

6.5.2.2. Middle East

6.5.2.2.1. Middle East market size and forecast, by application

6.5.2.3. Africa

6.5.2.3.1. Africa market size and forecast, by application

6.5.3. LAMEA market size and forecast, by application
6.5.4. LAMEA market size and forecast, by top selling drugs

CHAPTER 7: COMPANY PROFILES

7.1. AbbVie Inc.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. Astellas Pharma Inc.

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. Bristol Myers Squibb Company

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. Celgene Corporation

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. Eli Lilly and Company

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. F. Hoffmann-La Roche Ltd.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. EleInformatiBusiness performance
7.6.6. Key strategic moves and developments

7.7. Johnson & Johnson

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. Merck & Co., Inc.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. Novartis AG

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. Pfizer Inc.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments


【レポート販売概要】

■ タイトル:がん治療法の世界市場:用途別、人気商品別
■ 英文:Cancer Therapeutics Market by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others) and Top Selling Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日:2019年7月
■ 調査会社:Allied Market Research
■ 商品コード:AMR9NV072
■ 調査対象地域:グローバル
  • 石油・ガス産業向けプロセス安全システムの世界市場
    About Process Safety Systems Safety systems are designed to protect personnel and the environment during plant operations if/when a process goes beyond the defined control margins. There are various types of safety systems including fire and gas safety systems and burner gas management. These safety systems are used across various process industries such as Oil and Gas, Chemical, Refining, Power, …
  • 法的プロセスアウトソーシング(LPO)サービスの世界市場2017-2021
    About Legal Process Outsourcing Services LPO is the process of procuring legal services from an external provider. The cost of legal proceedings is increasing at a progressive pace. The outsourcing of these services is of strategic importance for law and corporate firms to reduce their expenditure on legal matters. LPO offers access to legal expertise from different countries and builds their core …
  • 自動車エンジニアリングサービスプロバイダー(ESP)の世界市場予測・分析2020-2024
    Global Automotive Engineering Service Providers (ESP) Market: About this market Technavio’s automotive engineering service providers (ESP)market analysis considers sales from the powertrain, complete vehicle, electrical/electronics, and other services. Our study also finds the sales of ESP in APAC, Europe, MEA, North America, and South America. In 2019, the powertrain segment had a significant mar …
  • Source-to-Pay(S2P)アウトソーシングの世界市場:Source-to-Contract(S2C)アウトソーシング、Procure-to-Pay (P2P) アウトソーシング
    About global S2P outsourcing S2P is an effective strategy that delegates one or more business activities to external companies (suppliers) that then administer and manage the selected activity based on defined and measurable performance criteria. It helps clients operate efficiently, reduces time to market, and helps focus on core competencies. S2P leads to the successful creation of an economical …
  • 空カプセルの世界市場・産業予測2016-2026
    The latest report from business intelligence provider visiongain offers comprehensive analysis of the global empty capsule market. The global empty capsules market was valued at $1,360m in 2015. Visiongain forecasts this market to increase to $1,944m in 2020. The market will then continue to increase to $3,074m in 2026, growing at a CAGR 6.8% between 2020 and 2026. How this report will benefit you …
  • マルチコプター・ドローンの世界市場:用途別、ペイロード別、地域別分析
    The multirotor drones market report offersa complete analysis of the market across the forecast period of five years from 2015 to 2020. It provides an analysis of the factors that drive the market, restrain the growth of the market, and the challenges faced by the industry. The major factors driving the market are the increasing use of drones in law enforcement and for non-military applications. H …
  • ベビー用食品・飲料の世界市場2016-2026
    The latest report from business intelligence provider visiongain offers comprehensive analysis of the global baby food & drink market. Visiongain assesses that this market will generate revenues of $59.36bn in 2016. Now: “Banker turned baby food maker sees start-up success”. This is an example of the business critical headline that you need to know about - and more importantly, you need to read vi …
  • HER2陰性乳癌治療薬の世界市場予測および分析
    PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-negative breast cancer market, with coverage of multiple settings …
  • 世界のラテックス・マットレス市場動向(2014~2018)
    TechNavio's analysts forecast the Global Latex Mattress market to grow at a CAGR of 14.87 percent over the period 2014-2018. One of the key factors contributing to this market growth is the need for environment-friendly products. The Global Latex Mattress market has also been witnessing the product innovation through R&D activities. However, the high cost of latex mattresses could pose a challenge …
  • バイオ燃料市場に関する理解:Understanding Biofuels
    The topic of biofuels has drawn increased interest worldwide in the wake of steeply-climbing fossil fuel prices in 2005-2006. In late 2006/early 2007 prices began to subside, but are unlikely to return to their former levels. The painful experience of national economies at the mercy of decisions taken far from their shores left a lasting impression on policymakers, and many nations now have a stro …
  • 世界のエステル市場2015
    The Global Esters Industry Report 2015 is a professional and in-depth study on the current state of the Esters industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Esters market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regio …
  • ジエチレングリコールビスアリルカーボネートの世界市場2015
    Diethyleneglycol bis-(allyl carbonate) (CAS 142-22-3) Market Research Report 2015 aims at providing comprehensive data on Diethyleneglycol bis-(allyl carbonate) market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Diethyleneglycol bis-(allyl carbonate) description, covers its application areas, manufacturing methods, patterns. It captures Diethyleneg …
  • バックヒートシール装置の世界市場2016-2020
    About Bag Heat Sealing Equipment Bag heat sealing equipment is used in sealing plastic material bags and pouches. Sealing of packaging products safeguards the products, checks their stability throughout the supply chain, and resists changes in temperature to maintain their quality and hygiene, thereby increasing the shelf life. Bag heat sealing equipment is used in the food, pharmaceutical, person …
  • ネットワーク分析ソリューションの世界市場:無線通信、VoIP、固定通信、ユニファイド・コミュニケーション
    The global network analytics market is estimated to grow at a CAGR of 25.6% from 2014 to 2019. Although the mature markets (such as the U.S. and the U.K.) hold larger shares in the network analytics market, the Asia-Pacific region is expected to grow at the highest CAGR of 32% during the forecast period. Growing network traffic, upgradation of technologies, Quality of Experience (QoE), maintenance …
  • Hugoton Royalty Trust:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013
    Hugoton Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Hugoton Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。